Literature DB >> 860939

Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs.

F Matuk, K Kalyanaraman.   

Abstract

We report two patients in whom the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) developed during the administration of psychotherapeutic drugs. In one, the syndrome occurred after administration of a phenothiazine drug and in the other, a butyrophenone. Both the patients were diagnostically studied for evidence of other disorders, either neurologic or systemic, which could cause this syndrome with negative results. They responded to fluid and free water restriction with remarkable recovery and no sequelae. It is stressed that psychotherapeutic drug administration must be considered as one of the iatrogenic causes of SIADH.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 860939     DOI: 10.1001/archneur.1977.00500180068015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  [Generalized compartment syndrome after excessive drinking. A rare complication of psychological disorders?].

Authors:  W M Franck; C H Schick; A Olk; F F Hennig
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

2.  Acute amitriptyline withdrawal and hyponatraemia. A case report.

Authors:  P Davison; J Wardrope
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 3.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 4.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

5.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.